Benefits of intensive multiple risk factor intervention

Slide lecture program (21 slides): View & Download

1. Potential benefits of multifactorial approaches
2. MRFIT: CVD mortality by diabetes status and number of baseline risk factors
3. Evidence base for multiple risk factor intervention: the STENO-2 study
4. STENO-2 study: Clinical outcomes
5. STENO-2 study: Residual CV risk
6. Risk factors for coronary artery disease
7. Approaches to CVD prevention in diabetes
8. The prevention of CV complications: a complex and multifactorial problem
9. Frequently used therapies in diabetes
10. Key findings from recent lipid-lowering trials
11. Statins reduce all-cause death: Meta-analysis of 14 trials
12. Benefits of aggressive LDL-C lowering in diabetes
13. CARDS: cumulative hazard for any CVD endpoint
14. Key findings from recent BP-lowering trials
15. Greater benefit from hypertension control in type 2 diabetes: Syst-Eur study
16. Risk reductions from intervention studies in type 2 diabetes
17. Targets for glycaemic control
18. Risk reduction in UKPDS 75
19. UKPDS 34: Intensive glucose control and CV protection

634919502817642500-Download PPAR section 2 (PPTX 413KB)

Benefits of intensive multiple risk factor intervention	Potential benefits of multifactorial approaches
MRFIT: CVD mortality by diabetes status	Evidence base for multiple risk factor intervention
STENO-2 study: Clinical outcomes	STENO-2 study: Residual CV risk
Risk factors for coronary artery disease	Summary
Approaches to CVD prevention in diabetes	The prevention of CV complications
Frequently used therapies in diabetes	Key findings from recent lipid-lowering trials
Statins reduce all-cause death	Benefits of aggressive LDL-C lowering in diabetes
CARDS: cumulative hazard for any CVD endpoint	Key findings from recent BP-lowering trials
Syst-Eur study	Risk reductions from intervention studies in type 2 diabetes
Targets for glycaemic control	Risk reduction in UKPDS 75
UKPDS 34: Intensive glucose control and CV protection